Godavari Drugs Ltd vs Onyx Biotec Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Godavari Drugs Ltd is ₹ 127.95 as of 18 May 15:30 . The P/E Ratio of Godavari Drugs Ltd changed from 8.4 on March 2021 to 15 on March 2025 . This represents a CAGR of 12.30% over 5 yearsThe P/E Ratio of Onyx Biotec Ltd changed from 21.3 on March 2025 to 21.3 on March 2025 . This represents a CAGR of 0.00% over 1 years The Market Cap of Godavari Drugs Ltd changed from ₹ 34.45 crore on March 2021 to ₹ 65.86 crore on March 2025 . This represents a CAGR of 13.84% over 5 yearsThe Market Cap of Onyx Biotec Ltd changed from ₹ 105.17 crore on March 2025 to ₹ 105.17 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Godavari Drugs Ltd for the Dec '25 is ₹ 22.45 crore as compare to the Sep '25 revenue of ₹ 27.28 crore. This represent the decline of -17.71% The revenue of Onyx Biotec Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Godavari Drugs Ltd for the Dec '25 is ₹ 2.75 crore as compare to the Sep '25 ebitda of ₹ 2.63 crore. This represent the growth of 4.56% The ebitda of Onyx Biotec Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Godavari Drugs Ltd changed from ₹ 1.63 crore to ₹ 0.76 crore over 6 quarters. This represents a CAGR of -39.87% The net profit of Onyx Biotec Ltd changed from ₹ 0 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of 0.0% The Dividend Payout of Godavari Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Onyx Biotec Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Godavari Drugs Ltd

Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates and fine chemicals catering to global life science industry.
It works a manufacturing plant at Nanded, Maharashtra, India.
Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand.
Company apart from its own products, explores continual opportunities for loan licence manufacturing with reputed multinational companies. The Company incorporated in December, 1987, has multiple production blocks for API's, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.

About Onyx Biotec Ltd

Onyx Biotec Limited was incorporated as Onyx Biotec Private Limited', pursuant to a Certificate of Incorporation dated May 13, 2005 issued by the Registrar of Companies, Punjab, H.P. & Chandigarh.
Further, Company converted into a Public Limited and the name was changed to Onyx Biotec Limited' and a fresh Certificate of Incorporation dated July 23, 2024 was issued by the Registrar of Companies, Central Processing Centre. Onyx started its operation in pharmaceutical industry with sterile water for injections with capacity of 2 lacs units per day in year 2010.
Since then, Onyx is engaged in Manufacturing of Pharmaceutical Products such as sterile water ampoule, dry injection, dry syrup etc. to major corporations, which includes the top pharma companies. Presently, the Company manufactures Sterile Water for Injections, and acts as a pharmaceutical contract manufacturer offering a comprehensive range of Dry Powder Injections and Dry Syrup for India and overseas.

FAQs for the comparison of Godavari Drugs Ltd and Onyx Biotec Ltd

Which company has a larger market capitalization, Godavari Drugs Ltd or Onyx Biotec Ltd?

Market cap of Godavari Drugs Ltd is 129 Cr while Market cap of Onyx Biotec Ltd is 61 Cr

What are the key factors driving the stock performance of Godavari Drugs Ltd and Onyx Biotec Ltd?

The stock performance of Godavari Drugs Ltd and Onyx Biotec Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Godavari Drugs Ltd and Onyx Biotec Ltd?

As of May 18, 2026, the Godavari Drugs Ltd stock price is INR ₹128.2. On the other hand, Onyx Biotec Ltd stock price is INR ₹33.8.

How do dividend payouts of Godavari Drugs Ltd and Onyx Biotec Ltd compare?

To compare the dividend payouts of Godavari Drugs Ltd and Onyx Biotec Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.